Literature DB >> 19501508

Antitumor activity of deoxypodophyllotoxin isolated from Anthriscus sylvestris: Induction of G2/M cell cycle arrest and caspase-dependent apoptosis.

Yeonjoong Yong1, Soon Young Shin, Young Han Lee, Yoongho Lim.   

Abstract

An active compound having antitumor activity was isolated from the root of Anthriscus sylvestris. Structural studies revealed that it was deoxypodophyllotoxin (DPPT), and its biological activity was evaluated in HeLa human cervix carcinoma cells. Flow cytometric analysis showed that DPPT arrests the cell cycle in the G2/M phase prior to apoptosis. The mechanisms of action of DPPT involve inhibition of tubulin polymerization, dysregulation of cyclin A and cyclin B1 expression, and activation of caspases-3 and -7.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19501508     DOI: 10.1016/j.bmcl.2009.05.093

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  12 in total

1.  [Effects of Sinopodophyllum hexundrum on apoptosis in K562 cells].

Authors:  Fang-Zhu Zhou; Xin Wang; An-Ya Dai; Zheng-Lan Huang; Hui Li; Ning-Shu Huang; Wen-Li Feng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

2.  Deoxypodophyllotoxin induces cell cycle arrest and apoptosis in human cholangiocarcinoma cells.

Authors:  Meifang Xiao; Xuegong Fan; Yongming Fu; Yujuan Zhou; Shaohui Liu; Shifang Peng
Journal:  Oncol Lett       Date:  2018-06-18       Impact factor: 2.967

3.  Anticancer effect of deoxypodophyllotoxin induces apoptosis of human prostate cancer cells.

Authors:  Sheng Hu; Qiang Zhou; Wan-Rui Wu; Yi-Xing Duan; Zhi-Yong Gao; Yuan-Wei Li; Qiang Lu
Journal:  Oncol Lett       Date:  2016-08-03       Impact factor: 2.967

4.  Design and synthesis of 6,7-methylenedioxy-4-substituted phenylquinolin-2(1H)-one derivatives as novel anticancer agents that induce apoptosis with cell cycle arrest at G2/M phase.

Authors:  Yi-Fong Chen; Yi-Chien Lin; Po-Kai Huang; Hsu-Chin Chan; Sheng-Chu Kuo; Kuo-Hsiung Lee; Li-Jiau Huang
Journal:  Bioorg Med Chem       Date:  2013-06-26       Impact factor: 3.641

Review 5.  Recent progress on C-4-modified podophyllotoxin analogs as potent antitumor agents.

Authors:  Ying-Qian Liu; Jing Tian; Keduo Qian; Xiao-Bo Zhao; Susan L Morris-Natschke; Liu Yang; Xiang Nan; Xuan Tian; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2014-05-14       Impact factor: 12.944

6.  Deoxypodophyllotoxin suppresses tumor vasculature in HUVECs by promoting cytoskeleton remodeling through LKB1-AMPK dependent Rho A activatio.

Authors:  Yurong Wang; Bin Wang; Mounia Guerram; Li Sun; Wei Shi; Chongchong Tian; Xiong Zhu; Zhenzhou Jiang; Luyong Zhang
Journal:  Oncotarget       Date:  2015-10-06

7.  Identification of anti-cancer chemical compounds using Xenopus embryos.

Authors:  Masamitsu Tanaka; Sei Kuriyama; Go Itoh; Aki Kohyama; Yoshiharu Iwabuchi; Hiroyuki Shibata; Masakazu Yashiro; Namiko Aiba
Journal:  Cancer Sci       Date:  2016-05-12       Impact factor: 6.716

8.  Highly loaded deoxypodophyllotoxin nano-formulation delivered by methoxy polyethylene glycol-block-poly (D,L-lactide) micelles for efficient cancer therapy.

Authors:  Chang Zu; Yinglan Yu; Caiwei Yu; Yi Li; Runing Sun; Birendra Chaurasiya; Baoqiang Tang; Daquan Chen; Jiasheng Tu; Yan Shen
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

9.  Anthricin Isolated from Anthriscus sylvestris (L.) Hoffm. Inhibits the Growth of Breast Cancer Cells by Inhibiting Akt/mTOR Signaling, and Its Apoptotic Effects Are Enhanced by Autophagy Inhibition.

Authors:  Chang Hwa Jung; Heemun Kim; Jiyun Ahn; Sung Keun Jung; Min Young Um; Kun-Ho Son; Tae Wan Kim; Tae Youl Ha
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-29       Impact factor: 2.629

10.  The effects of Gamijinhae-tang on elastase/lipopolysaccharide-induced lung inflammation in an animal model of acute lung injury.

Authors:  Sung-Hwa Sohn; HaRyeon Jang; Youngeun Kim; Young Pyo Jang; Seung-Hun Cho; Heejae Jung; Sungki Jung; Hyunsu Bae
Journal:  BMC Complement Altern Med       Date:  2013-07-16       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.